➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Mallinckrodt
Harvard Business School
Express Scripts
McKinsey

Last Updated: September 17, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for AZD9291


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug AZD9291?

AZD9291 is an investigational drug.

There have been 74 clinical trials for AZD9291. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2016.

The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, and Carcinoma. The leading clinical trial sponsors are AstraZeneca, National Cancer Institute (NCI), and Parexel.

There are one hundred and sixty-seven US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for AZD9291
TitleSponsorPhase
Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung CancerNational Cancer Institute (NCI)Phase 1/Phase 2
Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung CancerM.D. Anderson Cancer CenterPhase 1/Phase 2
Osimertinib Plus Chemotherapy vs Osimertinib in EGFRm NSCLC With Persistence Week-3 ctDNA EGFRm After 1L OsimertinibCancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2

See all AZD9291 clinical trials

Clinical Trial Summary for AZD9291

Top disease conditions for AZD9291
Top clinical trial sponsors for AZD9291

See all AZD9291 clinical trials

US Patents for AZD9291

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
AZD9291 ⤷  Try it Free Compositions and methods for treating cancer resistant to a tyrosine kinase inhibitor (TKI) Yeda Research and Development Co. Ltd. (Rehovot, IL) ⤷  Try it Free
AZD9291 ⤷  Try it Free 2-(2,4,5-substituted-anilino)pyrimidine compounds AstraZeneca AB (Sodertalje, SE) ⤷  Try it Free
AZD9291 ⤷  Try it Free Nuclear medicine diagnostic imaging agent Kyoto University (Kyoto, JP) ARKRAY, Inc. (Kyoto, JP) ⤷  Try it Free
AZD9291 ⤷  Try it Free Compositions comprising bacterial strains 4D Pharma Research Limited (GB) ⤷  Try it Free
AZD9291 ⤷  Try it Free Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-- trichlorophenyl)amino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide and methods of their use Signal Pharmaceuticals, LLC (San Diego, CA) ⤷  Try it Free
AZD9291 ⤷  Try it Free COX-2-targeting, platinum-containing conjugates and their use in the treatment of tumors and cancers REILEY PHARMACEUTICALS, INC. (San Jose, CA) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for AZD9291

Drugname Country Document Number Estimated Expiration Related US Patent
AZD9291 Australia AU2015313811 2034-09-08 ⤷  Try it Free
AZD9291 Canada CA2959775 2034-09-08 ⤷  Try it Free
AZD9291 European Patent Office EP3176183 2034-09-08 ⤷  Try it Free
AZD9291 European Patent Office EP3191523 2034-09-08 ⤷  Try it Free
AZD9291 Japan JP2017534574 2034-09-08 ⤷  Try it Free
AZD9291 World Intellectual Property Organization (WIPO) WO2016038610 2034-09-08 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Colorcon
Merck
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.